Literature DB >> 33673130

Discovery and Characterization of an ALFA-Tag-Specific Affinity Resin Optimized for Protein Purification at Low Temperatures in Physiological Buffer.

Markus Kilisch1, Hansjörg Götzke1, Maja Gere-Becker1, Alexander Crauel1, Felipe Opazo1,2,3, Steffen Frey1.   

Abstract

Epitope tags are widely employed as tools to detect, purify and manipulate proteins in various experimental systems. We recently introduced the ALFA-tag together with two ALFA-specific single-domain antibodies (sdAbs), NbALFA and NbALFAPE, featuring high or intermediate affinity, respectively. Together, the ALFA system can be employed for a broad range of applications in microscopy, cell biology and biochemistry requiring either extraordinarily stable binding or mild competitive elution at room temperature. In order to further enhance the versatility of the ALFA system, we, here, aimed at developing an sdAb optimized for efficient elution at low temperatures. To achieve this, we followed a stringent selection scheme tailored to the specific application. We found candidates combining a fast capture of ALFA-tagged proteins with an efficient competitive elution at 4 °C in physiological buffer. Importantly, by employing a structure-guided semisynthetic library based on well-characterized NbALFA variants, the high specificity and consistent binding of proteins harboring ALFA-tags at either terminus could be maintained. ALFA SelectorCE, a resin presenting the cold-elutable NbALFACE, is an ideal tool for the one-step purification of sensitive protein complexes or temperature-labile enzymes. We believe that the general approach followed during the selection and screening can be transferred to other challenging sdAb discovery projects.

Entities:  

Keywords:  ALFA Selector; ALFA system; affinity; cold-elutable; epitope tag; immunoprecipitation; nanobody; native elution; sdAbs; synthetic library

Year:  2021        PMID: 33673130      PMCID: PMC7918568          DOI: 10.3390/biom11020269

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  27 in total

1.  Structure and properties of a complex of α-synuclein and a single-domain camelid antibody.

Authors:  Erwin J De Genst; Tim Guilliams; Joke Wellens; Elizabeth M O'Day; Christopher A Waudby; Sarah Meehan; Mireille Dumoulin; Shang-Te Danny Hsu; Nunilo Cremades; Koen H G Verschueren; Els Pardon; Lode Wyns; Jan Steyaert; John Christodoulou; Christopher M Dobson
Journal:  J Mol Biol       Date:  2010-07-08       Impact factor: 5.469

2.  Nanobody approval gives domain antibodies a boost.

Authors:  Chris Morrison
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

3.  A new set of highly efficient, tag-cleaving proteases for purifying recombinant proteins.

Authors:  Steffen Frey; Dirk Görlich
Journal:  J Chromatogr A       Date:  2014-02-19       Impact factor: 4.759

Review 4.  Exploiting Nanobodies' Singular Traits.

Authors:  Jessica R Ingram; Florian I Schmidt; Hidde L Ploegh
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

Review 5.  Affinity and avidity in antibody-based tumor targeting.

Authors:  Stephen I Rudnick; Gregory P Adams
Journal:  Cancer Biother Radiopharm       Date:  2009-04       Impact factor: 3.099

6.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

7.  Nanobody immunostaining for correlated light and electron microscopy with preservation of ultrastructure.

Authors:  Tao Fang; Xiaotang Lu; Daniel Berger; Christina Gmeiner; Julia Cho; Richard Schalek; Hidde Ploegh; Jeff Lichtman
Journal:  Nat Methods       Date:  2018-11-05       Impact factor: 28.547

Review 8.  The Therapeutic Potential of Nanobodies.

Authors:  Ivana Jovčevska; Serge Muyldermans
Journal:  BioDrugs       Date:  2020-02       Impact factor: 5.807

9.  Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function.

Authors:  Benjamin Salzer; Christina M Schueller; Charlotte U Zajc; Timo Peters; Michael A Schoeber; Boris Kovacic; Michelle C Buri; Elisabeth Lobner; Omer Dushek; Johannes B Huppa; Christian Obinger; Eva M Putz; Wolfgang Holter; Michael W Traxlmayr; Manfred Lehner
Journal:  Nat Commun       Date:  2020-08-20       Impact factor: 17.694

10.  High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.

Authors:  Thomas J Esparza; Negin P Martin; George P Anderson; Ellen R Goldman; David L Brody
Journal:  Sci Rep       Date:  2020-12-22       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.